Kala Pharmaceuticals, Inc.
CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF
Last updated:
Abstract:
Described herein are certain crystalline forms of Compound 3, as well as pharmaceutical compositions employing the crystalline forms. Also provided are particles (e.g., nanoparticles) comprising such crystalline forms or pharmaceutical compositions. In certain examples, the particles are mucus penetrating particles (MPPs). The present invention further relates to methods of treating or preventing diseases using crystalline forms or pharmaceutical compositions.
Status:
Application
Type:
Utility
Filling date:
10 Mar 2021
Issue date:
18 Nov 2021